Accelerating Validation in Biopharma: How AI Transforms ELN Compliance and PQ Execution

Aug 18, 2026 | Artificial Intelligence, Testing & Validation

Biopharmaceutical R&D is undergoing a rapid digital transformation. Cloud-based informatics platforms, such as Electronic Lab Notebooks (ELNs), Laboratory Information Management Systems (LIMS), and related tools now drive scientific workflows, automate data capture, and streamline collaboration. Yet, despite these advances, the validation process required to deploy or update these systems remains one of the most complex and resource-intensive bottlenecks in GxP environments.

In regulated settings, every new configuration, workflow, or software release must undergo a rigorous Computer System Validation (CSV). Traditionally, this has meant hundreds of hours spent drafting manual test scripts, assembling documentation, and proving system accuracy and security. All too often, this results in delayed software rollouts and/or highly skilled talent bogged down by performing repetitive compliance tasks instead of advancing science.

As capable artificial intelligence (AI) models mature, traditional validation frameworks are rapidly evolving. Many organizations now use AI to generate draft validation deliverables to accelerate project timelines and shift validation engineers into higher-value roles as reviewers rather than script authors. Yet, despite AI’s strength in structuring documentation, total reliance on automated outputs introduces significant operational risk.

Below is a clear look at how AI is transforming validation – and where its limitations require human expertise to maintain compliance, reproducibility, and operational scalability.

GxP Validation Baseline: IQ, OQ, and PQ

Software validation in life sciences must align with stringent FDA expectations and follow a structured, evidence-based qualification model:

    • Installation Qualification (IQ): Verifies that the software is installed correctly within the designated infrastructure (e.g., a validated cloud environment) according to manufacturer specifications.
    • Operational Qualification (OQ): Confirms that the system’s discrete features, such as user roles, audit trails, and security boundaries, operate exactly as technically designed under defined conditions.
    • Performance Qualification (PQ): Demonstrates reliable performance in real-world scientific workflows, utilizing routine production conditions, actual biological or chemical data, and trained end-users.
Instead of writing test scripts for these specific phases of validation from scratch, QA teams are utilizing AI to ingest system requirement specifications, risk assessments, and intended use cases. Within seconds, the AI outputs comprehensive draft protocols and scripts.

Maintaining 21 CFR Part 11 and ALCOA+ Integrity

Introducing AI into compliance workflows raises understandable regulatory concerns. ELNs manage sensitive intellectual property, batch data, and experimental records, all of which must strictly comply with 21 CFR Part 11 requirements for trustworthy electronic records and signatures. It is important to clarify that across all phases of qualification – IQ, OQ, and PQ – integrating AI does not replace human accountability. The AI itself cannot “approve” scripts, apply compliant e-signatures, or validate scientific accuracy. Instead, the workflow leverages a “human-in-the-loop” model.

    • AI drafts structured documentation.
    • A qualified Subject Matter Expert (SME) reviews the output and verifies its scientific and technical accuracy.
    • The SME applies their compliant e-signature.
This approach preserves ALCOA+ principles while eliminating the administrative burden of writing scripts from scratch.

The Risk of Generalized PQ Steps

AI’s biggest limitation is its lack of real-time visibility into the software’s User Interface (UI). Models typically ingest process flows and system architecture documents rather than high fidelity UI maps. The AI cannot “see” the screen – it does not know if a critical “Sign and Lock” button is located in the top right corner, or if it is buried under a specific drop-down menu. Consequently, when asked to write a PQ test script, AI generates general, process driven steps rather than specific, click-by-click instructions. AI-generated PQ steps often look like:

    • Step 1: Navigate to the ELN creation module.
    • Step 2: Initiate a new record using the standard analytical template.
These steps are directionally correct but operationally insufficient. They lack the specificity required for reproducible, scalable testing across diverse user groups.

Why Click-by-Click Instructions Remain Essential for PQ Scripts

Legacy CSV models rely on deterministic, click-level PQ scripts:

    • Step 1: Click the ‘File’ tab in the upper left corner.
    • Step 2: Select ‘New Experiment’ from the drop-down list.
    • Step 3: Choose ‘Analytical Template v2.1’ and click ‘Proceed’.
In a GxP environment, reproducibility and traceability are paramount. Click-by-click PQ scripts provide an undeniable level of precision that generalized, intent driven AI steps simply cannot match. The manual, highly specific approach is ultimately superior for enterprise testing for a number of reasons:
    • Democratization of Testing Resources: When a PQ script is written with click-by-click precision, anyone can run it. An organization can utilize junior QA associates, external contractors, or generalist IT staff to execute the test scripts, even if they have never used that specific ELN before. The instructions guide them flawlessly through the UI.
    • SME Bandwidth Protection: If an AI-generated script simply says, “Initiate a new record,” only an experienced user who is already intimately familiar with the software’s UI can successfully execute the test. This forces organizations to pull highly skilled senior scientists and domain aware SMEs away from critical R&D work just to run routine validation scripts. This completely negates the time-saving benefits AI was supposed to deliver.
    • Error Reduction: Generalized instructions introduce interpretation risk. If an untrained tester misinterprets a vague AI instruction, they may take the wrong path in the software which results in a failed test and a costly deviation investigation. This is not because the software failed, but because the script lacked clarity. Click-by-click instructions eliminate this ambiguity and ensures standardized execution across multi-site global rollouts.
Precision is not a luxury in GxP – it is a compliance requirement.

The Path Forward: A Hybrid Validation Model for PQ Scripts

The drive to modernize biopharma compliance should not come at the expense of operational scalability. AI is a powerful tool for structuring initial validation documentation, generating high level requirement matrices, and drafting initial protocols. But it is not a standalone solution for PQ script development. The most effective model for PQ script generation is hybrid:

    • Step 1: AI generates structured drafts.
    • Step 2: Human validation engineers inject granular, click-by-click UI detail.
    • Step 3: SMEs verify scientific accuracy and apply compliant signatures.
This approach preserves regulatory integrity, reduces execution bottlenecks, and ensures scripts are accessible to a wide pool of testers – delivering validation without frustration.
Mary Beth Walsh
About The Author

Eric Tucker

Eric Tucker is currently a Research and Development Consultant at Kalleid, where he uses his knowledge in biomedical sciences to evaluate and write clinical trial test scripts, and support largescale data migrations as well as supporting ELN adoption for major pharmaceutical clients.  He has extensive experience developing cellbased assays, ELISA panels, and immunology protocols that support both internal R&D initiatives and clientdriven research programs. With deep technical expertise across human and murine primary cells, engineered immune cell types, and cancer cell lines, he is skilled in designing, validating, and optimizing complex workflows that advance translational research and product innovation.

Eric holds an MS in Biomedical Science from Rutgers Graduate School of Biomedical Sciences and a BS in Biology from Cornell College.

About Kalleid

Kalleid, Inc. is a boutique IT consulting firm that has served the scientific community since 2014. We work across the value chain in R&D, clinical, and quality areas to deliver support services for software implementations in highly complex, multi-site organizations. At Kalleid, we understand how effective project management plays a key role in ensuring the success of your IT projects. Kalleid project managers have the right mix of technical know-how, domain knowledge and soft skills to effectively manage your project over its full lifecycle. From project planning to go-live, our skilled PMs will identify and apply the most effective methodology (e.g., agile, waterfall, or hybrid) for successful delivery. If you are interested in exploring how Kalleid project managers can benefit your organization, please don’t hesitate to contact us today.